Published in

Royal Society of Chemistry, Nanoscale, 11(14), p. 4098-4113, 2022

DOI: 10.1039/d1nr08170e

Links

Tools

Export citation

Search in Google Scholar

Engineered mesenchymal stem cell-derived exosomes with high CXCR4 levels for targeted siRNA gene therapy against cancer

Journal article published in 2022 by Shuyue Xu, Bin Liu, Junyi Fan, Cuili Xue ORCID, Yi Lu, Can Li, Daxiang Cui ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The mesenchymal stem cells were genetically engineered to obtain exosomes with high CXCR4 expression as carriers for targeted gene-drug delivery.